15.05.2018 13:40:08

CRISPR Therapeutics Buy

Der Analyst Chardan Capital Markets hat das Kursziel für CRISPR Therapeutics AG von 25 auf 72,5 USD angehoben, aber die Einstufung auf "Buy" belassen.
Zusammenfassung: CRISPR Therapeutics AG Buy
Unternehmen:
CRISPR Therapeutics AG
Analyst:
Chardan Capital Markets
Kursziel:
$ 72.50
Rating jetzt:
Buy
Kurs*:
48.40 €
Abst. Kursziel*:
49.79%
Rating update:
reiterated
Kurs aktuell:
$ 48.67
Abst. Kursziel aktuell:
48.96%
Analyst Name::
-
KGV*:
-
* Zum Zeitpunkt der Analyse

Analysen zu CRISPR Therapeutics AGmehr Analysen

15.05.18 CRISPR Therapeutics Buy Chardan Capital Markets
28.03.17 CRISPR Therapeutics Buy Chardan Capital Markets
14.11.16 CRISPR Therapeutics overweight Barclays Capital

Eintrag hinzufügen

Aktien in diesem Artikel

CRISPR Therapeutics AG 48.40 -2.36% CRISPR Therapeutics AG

Aktuelle Aktienanalysen

17.08.18 Goldman Sachs Group Inc.
HUGO BOSS Sell
17.08.18 Credit Suisse Group
Air France-KLM Neutral
17.08.18 Telsey Advisory Group
Zoes Kitchen Market Perform
17.08.18 Goldman Sachs Group Inc.
Siemens Healthineers Neutral
17.08.18 RBC Capital Markets
Fresenius Medical Care Sector Perform
17.08.18 BMO Capital Markets
Diamondback Energy Market Perform
17.08.18 BMO Capital Markets
Constellation Pharmaceuticals Outperform
17.08.18 BMO Capital Markets
Central Garden & Pet Outperform
17.08.18 BMO Capital Markets
Replimune Group Outperform
17.08.18 Canaccord Adams
Retrophin Buy
17.08.18 Noble Financial Group
CACI International Hold
17.08.18 RBC Capital Markets
Walmart Sector Perform
17.08.18 Morningstar
Alphabet C (ex Google) Hold
17.08.18 Oppenheimer & Co. Inc.
Alphabet C (ex Google) Outperform
17.08.18 Oppenheimer & Co. Inc.
Amazon Outperform
17.08.18 Jefferies & Company Inc.
Amazon buy
17.08.18 RBC Capital Markets
Walmart Outperform
17.08.18 Stifel, Nicolaus & Co., Inc.
Walmart Hold
17.08.18 Credit Suisse Group
Walmart Neutral
17.08.18 The Benchmark Company
JDcom Buy
17.08.18 Lake Street
AquaVenture Buy
17.08.18 Telsey Advisory Group
Nordstrom Outperform
17.08.18 CFRA
Henkel vz Sell
17.08.18 Chardan Capital Markets
Amicus Therapeutics Neutral
17.08.18 JP Morgan Chase & Co.
Walmart Neutral
17.08.18 Cowen and Company, LLC
NVIDIA Outperform
17.08.18 Stifel, Nicolaus & Co., Inc.
NVIDIA Hold
17.08.18 Stifel, Nicolaus & Co., Inc.
EQT Midstream Partners LP Patnership Interest Buy
17.08.18 Goldman Sachs Group Inc.
Lloyds Banking Group Sell
17.08.18 Stifel, Nicolaus & Co., Inc.
JDcom Buy
17.08.18 Goldman Sachs Group Inc.
Philips Conviction Buy
17.08.18 HSBC
Ceconomy St buy
17.08.18 Stifel, Nicolaus & Co., Inc.
Viper Energy Partners LP Partnership Units Buy
17.08.18 HSBC
Bayer Hold
17.08.18 Telsey Advisory Group
J C Penney Company Market Perform
17.08.18 Credit Suisse Group
Glencore Outperform
17.08.18 Oppenheimer & Co. Inc.
NVIDIA Outperform
17.08.18 DZ BANK
Grand City Properties Halten
17.08.18 Oppenheimer & Co. Inc.
Yum China Perform
17.08.18 Jefferies & Company Inc.
Nestlé Hold
17.08.18 Citigroup Corp.
pbb Neutral
17.08.18 Citigroup Corp.
Aareal Bank Neutral
17.08.18 UBS AG
STMicroelectronics Sell
17.08.18 Goldman Sachs Group Inc.
Intesa Sanpaolo Neutral
17.08.18 Goldman Sachs Group Inc.
BNP Paribas Conviction Buy List
17.08.18 Goldman Sachs Group Inc.
ING Group buy
17.08.18 Goldman Sachs Group Inc.
UniCredit Conviction Buy
17.08.18 Goldman Sachs Group Inc.
BBVA Neutral
17.08.18 UBS AG
CRH buy
17.08.18 UBS AG
Vestas Wind Systems A-S buy